Page 48 - Read Online
P. 48

J Cancer Metastasis Treat 2020;6:5  I  http://dx.doi.org/10.20517/2394-4722.2020.13                                               Page 23 of 38

               Autophagy, a lysosome-driven catabolic process for degradation of self-constituents, participates in the
               stress response for maintaining cell homeostasis. It has been shown that autophagy is down-regulated
               during cell locomotion, while it is induced when cells arrest their migration.

               We found that pro-inflammatory cytokines promote cancer cell migration following down-regulation of
               autophagy in the migratory cells. We also investigated at the molecular level the mechanisms through
               which the cytokines modulate autophagy.

               Our data highlight the role of autophagy in cancer cell EMT and migration, offering opportunities for
               therapeutic interventions to prevent invasion and metastasis.


               32. Vasculogenic mimicry in glioblastoma and melanoma


               Luca Colucci-D’Amato, Maria Teresa Gentile, Olga Pastorino

               Laboratory of Molecular and Cellular Neuropathology, Department of Environmental, Biological and
               Pharmaceutical Science and Technology, University of Campania “L. Vanvitelli”, Caserta 81100, Italy.

               Background and aim: Neo-angiogenesis is the most studied mechanism of vascularization in tumors
               and refers to sprouting of new blood vessels from pre-existing ones and it may be inhibited by natural
               compounds. Vasculogenic mimicry (VM) is an alternative mechanisms of tumor vascularization providing
               a means by which some tumors can escape anti-angiogenetic therapy. VM occurs in glioblastoma (GBM)
               and melanoma, both tumors of neuroepithelial derivation. We investigated the role of REST/NRSF gene in
               the pathophysiology of VM as well as the effects of compounds such as the histone deacetylase inhibitors
               (HDACis) to interfere with VM.


               Experimental procedure: To measure tube formation, cell migration, and invasion, we used: in vitro tube
               formation assay on Matrigel, Boyden chamber migration assay, wound healing assay, invasion test, and
               real-time migration monitoring. To measure cell viability, we used: MTT and trypan blue exclusion test. To
               transfect cells, we used: lipofectamine standard protocol.

               Results: We analyzed a number of GBM and melanoma cell lines. We found that the expression of REST
               parallels the ability to migrate and to form tubes on Matrigel. Upon genetic or chemical down-regulation of
               REST (via siRNA or dominant negative mutant or HDACi), we observed a decrease in migration ability as
               well as tube formation. Finally, we found that different histone deacetylase inhibitors impair vasculogenic
               mimicry from glioblastoma cells.

               Conclusions: Our findings show that REST/NRSF gene is an important molecular player in the
               pathophysiology of vasculogenic mimicry in GBM and melanoma and that HDAC inhibitors alone can
               impair the formation of tubes from GBM cells.


               33. Mouse tumor susceptibility alleles identify pathways for intervention in multiple myeloma

               Beverly A. Mock


               Laboratory of Cancer Biology & Genetics, Center for Cancer Research, National Cancer Institute, National
               Institutes of Health, Bethesda, MD 20892, USA.
   43   44   45   46   47   48   49   50   51   52   53